Minnesota Cannabis Law Changes August 1, 2026: Your Complete Guide to the Omnibus Bill

Updated October 14, 2026: This law has phased effective dates. The unified medical/adult-use supply chain, new medical endorsement requirements, high medical need product availability enforcement, and ratio hemp-infused cannabis product category begin January 1, 2027. They are not August 1 changes.

On May 26, 2026, Governor Tim Walz signed the 2026 Omnibus Cannabis Bill into law, setting in motion the most sweeping overhaul of Minnesota's cannabis regulations since adult-use sales launched in 2025. Sponsored by Representative Jessica Hanson (DFL-Burnsville) and described by Hanson as a "collaborative effort" involving more than 80 stakeholders, the law touches nearly every corner of the industry, from supply chain logistics and medical patient access to hemp industry lifelines and a brand-new license tier.

The law has several effective dates, including provisions already in effect and a substantial medical-market transition on January 1, 2027. Read each section on its own timeline; the medical and supply-chain changes below do not begin August 1, 2026.

What Changes on August 1, 2026

1. Dual Licensure: Hemp Operators Can Enter the Cannabis Market

One of the most significant lifelines in the bill is directed at Minnesota's hemp industry. The law authorizes dual licensure, allowing the same ownership group to hold both hemp and cannabis (marijuana) licenses simultaneously. Previously, those markets were walled off from each other at the ownership level.

This matters enormously in light of the federal regulatory calendar. A federal re-definition of "hemp" is set to take effect Dec. 11, 2026 (delayed from Nov. 12 by a law signed Sept. 2, 2026), which will significantly narrow what can legally be sold under federal hemp rules. The Minnesota legislation gives hemp operators a runway to transition into the regulated cannabis market before that federal shift squeezes their product options.

2. OCM Gets Broader Enforcement Authority

The Office of Cannabis Management gains expanded powers under the new law. Starting August 1:

OCM may deny or revoke licenses on broader grounds, with clearer authority to act on compliance failures.
Preliminary license approvals must include mandatory extension rights, giving applicants more protection during the approval pipeline.
OCM transitions to a streamlined reporting structure: one annual market analysis and one consolidated legislative report due by January 15 each year. The previous reporting framework had become unwieldy, and the new bifurcated structure is intended to prioritize useful public health, safety, and market data.

3. Local Government Licensing Rules Get Standardized

The law requires local governments to adopt reasonable cannabis regulations and to apply population-based licensing thresholds using upward rounding. This provision addresses patchwork local rules that had created inconsistency across municipalities in how many dispensaries could operate per capita.

4. Social Equity Applicants Can Hold More Licenses

Social equity license applicants may now hold up to four licenses with capped ownership stakes. Previously, license caps were more restrictive for social equity operators, limiting the scale of businesses that could be built by qualifying individuals. This change is intended to support wealth-building opportunities for communities disproportionately affected by cannabis prohibition.

5. Cannabis and Hemp Activities Expressly Protected Under State Law

The new law codifies explicit protections for compliant cannabis and hemp business activities under Minnesota state law. This is a legal housekeeping provision, but an important one: it creates clearer ground for businesses to operate without civil liability risk from state-level interference, even as federal status remains complicated.

What Changes on January 1, 2027

One Supply Chain for Medical and Adult-Use Businesses — January 1, 2027

The law converts medical cannabis combination businesses to macrobusinesses and revises medical cultivation, manufacturing, and retail endorsements beginning January 1, 2027 (sections 96–98, 103, and 119). OCM describes this transition as streamlining medical and adult-use supply chains. Operators should confirm implementation and tracking instructions with OCM before changing their systems; the statute does not specify a single Metrc instance.

Medical Endorsement Requirements — January 1, 2027

The new medical retail endorsement provisions begin January 1, 2027. Medical-endorsed retailers must provide the required pharmacist or certified medical cannabis consultant coverage, ensure required consultations are available, give registered patients and caregivers priority service, and carry the products OCM identifies as high medical need. Existing patient consultation requirements continue to apply before that transition.

OCM published its high medical need product list on October 12, 2026. Our medical product requirements guide explains the product categories and what patients can ask a retailer to confirm.

Also effective January 1, 2027, section 102 allows OCM to suspend or revoke a medical endorsement if a business does not make the identified high medical need products available at each retail location within 24 hours of a patient request. This provision concerns those designated products; it is not a current promise of delivery, every brand, or every product requested.

Ratio Hemp-Infused Cannabis Products — January 1, 2027

Beginning January 1, 2027, the law creates a new product category: ratio hemp-infused cannabis products. These must stay within the following limits:

No more than 100 milligrams of CBD, CBG, CBN, or CBC per serving.
No more than 10 milligrams of THC per serving.
No more than 200 milligrams of THC per package for edibles, or two servings per container for beverages.

Explore Minnesota's current cannabis product landscape and strain options to understand where these new formulations fit within the broader market.

The New Macrobusiness License

The existing medical cannabis combination business license will sunset on January 1, 2027. In its place, the law creates the macrobusiness license, a new top-tier category in Minnesota's size-tiered licensing structure.

Key parameters of the macrobusiness license:

Up to 38,000 square feet of indoor plant canopy. This is a significant reduction from the current 90,000 square feet allowed for medical cannabis combination businesses.
Up to eight retail locations. If a macrobusiness operates more than five retail locations, at least three must be located in areas OCM designates as high medical need.
A statewide cap of eight macrobusiness licenses until January 1, 2030.
Macrobusinesses are the only license type required to serve the medical market, and they must hold at least two medical endorsements.

For operators concerned about the canopy reduction, the law does include a gradual restoration path: macrobusinesses in good standing can earn back canopy through license renewals, gaining an additional 2,000 square feet after their first renewal, another 2,000 after the second, and an additional 3,000 after the third.

All existing medical cannabis combination business licenses must be converted to macrobusiness licenses or applications by January 1, 2027. OCM is responsible for managing that conversion process.

Representative Nolan West (R-Blaine) called the canopy reduction "the worst part of the bill," warning it could invite litigation from current operators who built their businesses around larger canopy allowances. That tension is worth watching as implementation proceeds.

The law also introduces a petition process for microbusinesses and mezzobusinesses that want to move into a higher license tier, with priority given to businesses holding medical endorsements and equal allocation between social equity and non-social equity applicants.

Incentives for Medical Endorsement Holders

Beginning January 1, 2027, the new endorsement provisions authorize benefits for eligible license types, subject to the relevant endorsement and its conditions:

Expanded cultivation limits above what non-endorsed businesses may grow.
Rights to operate additional retail locations in designated high medical need areas.
A new medical cannabis delivery endorsement for a macrobusiness with a medical retail endorsement or a cannabis delivery license holder. A medical retail endorsement alone does not authorize delivery.

For medical cultivation endorsement holders, section 96 requires at least one quarter of all flower cultivated annually to be sold to a medically endorsed business, including the same license holder when it also has a medical manufacturing or retail endorsement.

What This Means for Consumers

If you are a Minnesota cannabis consumer or patient, here is the practical takeaway:

Medical patients can use OCM’s published product list to ask retailers about availability now. The new medical endorsement requirements and high medical need product availability enforcement begin January 1, 2027; they do not establish a current 24-hour guarantee for every requested product.

Adult-use consumers will notice fewer differences in the short term. The January 1 medical-market transition primarily affects business operations; dispensary shelves and the retail experience should remain largely consistent. Over time, the macrobusiness framework and expanded cultivation rights may shift which operators dominate the market.

Hemp consumers should pay attention to the new ratio hemp-infused cannabis products when they begin appearing in licensed dispensaries. These products are formulated within defined cannabinoid limits and will be sold through the regulated cannabis supply chain, meaning they come with the same testing and labeling standards as other cannabis products. Check out the legal overview for Minnesota cannabis to understand how the regulatory environment is evolving.

What This Means for Dispensaries and Businesses

If you operate or plan to open a Minnesota dispensary, here is what to prepare for the January 1, 2027 medical-market transition:

Evaluate your Metrc configuration. Review OCM implementation and tracking instructions for the January 1 licensing transition before changing your Metrc setup.
Review your staffing. The pharmacist or medical cannabis consultant requirement is mandatory for retail medical endorsement holders. Begin hiring or contracting if you do not have this role filled.
Audit your patient service protocols. Prepare required priority service and high medical need product availability for January 1, 2027. The 24-hour enforcement provision concerns OCM-designated high medical need products at each retail location, rather than every requested product or home delivery.
If you operate a hemp business, consult legal counsel about dual licensure and the federal Dec. 11, 2026 deadline. The window to plan a transition into the cannabis market is open now; confirm the latest federal and OCM guidance before making inventory or licensing decisions.
Watch OCM guidance on macrobusiness conversion. If you are a current medical cannabis combination business, the January 1, 2027 deadline is coming faster than it looks. OCM will issue conversion procedures; stay close to those communications.

Frequently Asked Questions

When does the 2026 Omnibus Cannabis Bill take effect?

The law has phased effective dates. The medical/adult-use supply-chain change, new medical endorsement requirements, high medical need product availability enforcement, ratio hemp-infused cannabis product category, and macrobusiness framework begin January 1, 2027. Other provisions began earlier; check the effective date of the specific section.

What is the new macrobusiness license in Minnesota?

The macrobusiness license is a new top-tier cannabis license that replaces the existing medical cannabis combination business license. It allows up to 38,000 square feet of indoor canopy and up to eight retail locations. It is the only license type required to serve the medical market. The macrobusiness license becomes available January 1, 2027, with a statewide cap of eight licenses until 2030.

Can hemp and cannabis businesses be owned by the same person under Minnesota's new law?

Yes. Starting August 1, 2026, the law allows dual licensure, meaning the same owner can hold both hemp and cannabis licenses. This was not permitted under the previous framework.

What are the rules for the new ratio hemp-infused cannabis products?

Beginning January 1, 2027, ratio hemp-infused cannabis products must contain no more than 100 milligrams of CBD, CBG, CBN, or CBC per serving, no more than 10 milligrams of THC per serving, and no more than 200 milligrams of THC per package for edibles (or two servings per container for beverages). They will be sold through the licensed cannabis supply chain.

Do medical patients get better protections under the new law?

The new medical retail endorsement provisions begin January 1, 2027. They require pharmacist or certified consultant coverage, required consultations, priority service, and all OCM-designated high medical need products. Section 102 also enables endorsement suspension or revocation when those products are not available at each retail location within 24 hours of a patient request. Existing consultation requirements continue before January 1; this is not a current blanket 24-hour fulfillment guarantee.

Does the new law change what dispensaries must carry or how they price products?

The new provisions do not set retail prices. Beginning January 1, 2027, medical-endorsed retailers must carry all products OCM designates as high medical need. Macrobusinesses, which are the only license type required to serve the medical market, must maintain retail locations in high medical need areas if they operate more than five locations.

How does this law affect social equity cannabis license applicants?

Social equity applicants may now hold up to four cannabis licenses with capped ownership stakes, an increase from the previous limit. The petition process for moving into higher license tiers also gives priority to social equity applicants.

Where to Learn More

The full text of the 2026 Omnibus Cannabis Bill is available at the Minnesota Office of the Revisor of Statutes. Legal analysis from Foley Hoag LLP and Harris Sliwoski LLP provide additional detail on licensing implications. The MN House Session Daily covered the bill's passage with commentary from the bill sponsors.

For directory location and reported service details, visit mncannabishub.com/dispensaries. For ongoing updates on Minnesota cannabis law, bookmark our legal coverage section.